Alnylam Pharmaceuticals
ALNY
#624
Rank
โ‚ฌ30.29 B
Marketcap
234,84ย โ‚ฌ
Share price
1.06%
Change (1 day)
37.39%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company